In terms of Regulation 29 (1) (a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Abbott India has informed that a meeting of the Board of Directors of the company is scheduled to be held on Friday, February 8, 2019, to consider and approve the text of Unaudited Financial Results of the company for the third quarter and nine months ended on December 31, 2018. Further, in terms of the company’s Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window of the company shall remain closed from Friday, February 1, 2019 to Sunday, February 10, 2019.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1486.35 |
Dr. Reddys Lab | 5962.50 |
Cipla | 1400.00 |
Zydus Lifesciences | 933.40 |
Lupin | 1580.00 |
View more.. |